Breakthrough Cancer Research has provided €1 million in funding for a new treatment targeting inflammation in Barrett’s patients. The funding is also supported by industry and other charities like the Oesophageal Cancer Fund and Cross. Prof Jacintha O’Sullivan and PhD student Lorraine Smith announced the treatment, which aims to accelerate discoveries in the oesophageal cancer patient journey from prevention to survivorship. The researchers are part of the All-Ireland AllCaN-Oesophageal Network, a collaboration of scientists, clinicians, industry partners, and patient groups in Ireland. The announcement was made ahead of World Barrett’s Oesophagus Day on May 16. More information is available at breakthroughcancerresearch.ie.
Source link
New treatment funded by Breakthrough Cancer Research
